Your browser doesn't support javascript.
loading
Tildrakizumab for the treatment of moderate to severe psoriasis: Results from a single center preliminary real-life study.
Ruggiero, Angelo; Potestio, Luca; Cacciapuoti, Sara; Gallo, Lucia; Battista, Teresa; Camela, Elisa; Fabbrocini, Gabriella; Megna, Matteo.
Afiliação
  • Ruggiero A; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Potestio L; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Cacciapuoti S; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Gallo L; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Battista T; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Camela E; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Megna M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
Dermatol Ther ; 35(12): e15941, 2022 12.
Article em En | MEDLINE | ID: mdl-36239544
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article